biocryst.com (BCRX): Dana dhuwit perusahaan

BCRX (BioCryst Corp) - tandha merek perusahaan

BioCryst maintains a high level of authority in the therapy of rare immune pathologies, developing vital tablets for hereditary angioedema. The current cash balance confirms financial stability, where 0.38 represents the current metric. A monopoly position in the pricing of unique medications ensures high margins, while the expansion of the prescription base optimizes marketing and R&D expenses.

BioCryst Pharmaceuticals Inc - Cadangan dhuwit perusahaan BCRX (periode 04.07.2022 - 21.11.2026)

Rincian metrik komprehensif lan analitis BioCryst Pharmaceuticals (BCRX)

- kuotasi lan prakiraan analis:
Analisis umum perusahaan:biocryst.com
Sampel barang biocryst.com

Liquidity is critical for BioCryst (BCRX) to sustain costly developments in protein crystallography and enzyme technologies without resorting to external loans. By analyzing cash reserve dynamics, an investor determines the company's ability to self-fund R&D investments and expansion to avoid business stagnation and missed profit opportunities amid the growth of the biopharmaceutical market.

Pesaing BioCryst

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|VERA (Vera Pharma) - Sisa dhuwit perusahaan|Dianthus Pharma - Dhuwit awis perusahaan|Sisa dhuwit perusahaan PHVS|AbCellera Biologics - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan TRML (Tourmaline Bio)|PGEN: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Pharming Group N.V. (PHAR)|Dana dhuwit perusahaan Nektar|upstreambio.com (UPB) - Aset likuid perusahaan|Dana dhuwit perusahaan Zenas Bio (ZBIO)|Aset likuid perusahaan Immunome Inc|Dana dhuwit perusahaan Gossamer Bio, Inc. GOSS|Volume dana dhuwit perusahaan KalVista Pharmaceuticals Inc KALV|SEPN - Dana dhuwit perusahaan|PVLA - Volume dana dhuwit perusahaan|SVRA: Volume dana dhuwit perusahaan|RIGL - Aset likuid perusahaan|ANAB (AnaptysBio Inc) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Astria Corp (ATXS)|Volume dana dhuwit perusahaan ENGN|Aset likuid perusahaan rapt.com|Volume dana dhuwit perusahaan JBIO (Aerovate Therapeutics Inc)|Aset likuid perusahaan Aclaris Therapeutics, Inc. (ACRS)|KYTX - Dana dhuwit perusahaan|Aset likuid perusahaan Tiziana Life Sciences TLSA|CABA: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan VTYX|Dhuwit awis perusahaan THTX|Volume dana dhuwit perusahaan Avalo Therapeutics Inc.|Dana dhuwit perusahaan Eledon (ELDN)|Volume dana dhuwit perusahaan Agenus Inc (AGEN)|Volume dana dhuwit perusahaan CLYM (climbbio.com)|ZURA - Dhuwit awis perusahaan|atyrpharma.com - Volume dana dhuwit perusahaan|ADAG (adagene.com) - Dhuwit awis lan setara dhuwit awis perusahaan|IMA (Ikena Oncology) - Dhuwit awis perusahaan|Dhuwit awis perusahaan Shattuck Labs Inc|EQ (Equillium Inc) - Volume dana dhuwit perusahaan|CNTB: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IMUX|ATRA (Atara Biotherapeutics, Inc.) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IFRX (inflarx.de)|X4 Pharmaceuticals - Dana dhuwit perusahaan|Adicet Bio, Inc. - Volume dana dhuwit perusahaan|CELU (celularity.com) - Dhuwit awis lan setara dhuwit awis perusahaan|INMB: Volume dana dhuwit perusahaan|Barinthus Biotherapeutics PLC (BRNS) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Kezar Life Sciences|Dhuwit awis perusahaan SAB Biotherapeutics (SABS)|Dana dhuwit perusahaan Akari Therapeutics Plc (AKTX)|Dhuwit awis perusahaan Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Dhuwit awis perusahaan|GeoVax Labs (GOVX) - Cadangan dhuwit perusahaan|edesabiotech.com - Volume dana dhuwit perusahaan|Aset likuid perusahaan iBio Corp IBIO|CARM: Volume dana dhuwit perusahaan|xtlbio.com (XTLB) - Volume dana dhuwit perusahaan|BOLT (Bolt Biotherapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan HCW Biologics (HCWB)|Dhuwit awis perusahaan APVO (Aptevo Therapeutics)|AIM - Cadangan dhuwit perusahaan|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD